- ... of blood relatives with prostate cancer and young age at onset of prostate cancer within families.[ 28 ] There is considerable controversy in prostate cancer about the use of serum prostate-specific antigen (PSA) measurement and digital rectal exam for prostate cancer early ...
- ... and 36.4 for African American men.[ 2 ] Age-adjusted incidence rates increased steadily from 1975 through 1992, with particularly dramatic increases associated with the inception of widespread use of prostate-specific antigen (PSA) screening in the late 1980s and early ...
- ... as other PSA-based prognostic measures, such as age-adjusted thresholds, velocity, and ... “early diagnosis,” “PSA velocity,” “PSA doubling time,” and “ ...
- ... of tumor . Histologic grade of tumor . Patient's age and health . Prostate-specific antigen (PSA) level . (Refer to the Surveillance, Epidemiology, and ... of this summary for more information.) Patient's age and health Any benefits ... antigen (PSA) level PSA, an organ-specific marker, is ...
- NLM Digital Collections - Medicare laboratory test expenditures increased in 2018, despite new rate reductionsPublication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, August 2020... 08 including metabolite(s) if performed (G0481) 17 PSA (prostate specific antigen) measurement (84153) $25.23 $22.71 4.30 $95. ...
- NLM Digital Collections - Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer : effectiveness ...Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018... resistant prostate cancer PFS Progression-free survival PSA Prostate specific antigen QALY Quality-adjusted life year QLQ-PR25 Quality of Life Questionnaire— ...
- ... variants.[ 424 , 462 ] Notwithstanding prevalent controversy surrounding routine prostate-specific antigen (PSA) screening, the authors suggested that screening by means of PSA and digital rectal exam beginning at age 40 years in male MMR gene carriers would ...
- ... predictors of time to cancer specific death after prostate specific antigen failure. J ... and survival in men of advanced age with node-negative high-risk adenocarcinoma of the ...
- NLM Digital Collections - Proton beam therapy : final evidence reportPublication: [Boston, MA] : Institute for Clinical and Economic Review, [2014]... therapy for prostate cancer: a rise in the prostate-specific antigen (PSA) ... biochemical measurements associated with liver function. For each item, up ...
- ... health status in men with benign prostatic hyperplasia. Measurement Committee of The ... antigen testing for early detection of prostate cancer? Part ...
133 results